115 related articles for article (PubMed ID: 23967)
21. Intrarenal vascular effects of angiotensin II and angiotensin III in the dog.
Britton SL; Fiksen-Olsen MJ; Houck PC; Romero JC
J Hypertens; 1983 Jun; 1(1):95-101. PubMed ID: 6681031
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
Kawasaki H; Cline WH; Su C
J Pharmacol Exp Ther; 1984 Oct; 231(1):23-32. PubMed ID: 6149303
[TBL] [Abstract][Full Text] [Related]
23. Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Takatori S; Zamami Y; Mio M; Kurosaki Y; Kawasaki H
Hypertens Res; 2006 May; 29(5):361-8. PubMed ID: 16832157
[TBL] [Abstract][Full Text] [Related]
24. Blockade by saralasin of adrenergic potentiation induced by renin-angiotensin system.
Zimmerman BG; Kraft E
J Pharmacol Exp Ther; 1979 Jul; 210(1):101-5. PubMed ID: 448637
[TBL] [Abstract][Full Text] [Related]
25. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
26. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
Susić H; Malik KU
J Pharmacol Exp Ther; 1981 Nov; 219(2):377-82. PubMed ID: 6793715
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin effects on vas deferens adrenergic and purinergic neurotransmission.
Trachte GJ
Eur J Pharmacol; 1988 Feb; 146(2-3):261-9. PubMed ID: 2836209
[TBL] [Abstract][Full Text] [Related]
28. In vitro neurogenic and musculotropic responses to angiotensin peptides in normal and sodium-restricted rabbits.
Sybertz EJ; Peach MJ
Circ Res; 1980 Jun; 46(6):836-42. PubMed ID: 6103756
[No Abstract] [Full Text] [Related]
29. Demonstration of different contractile mechanisms for angiotensin II and des-Asp1-angiotensin II in rabbit aortic strips.
Ackerly JA; Moore AF; Peach MJ
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5725-8. PubMed ID: 271997
[TBL] [Abstract][Full Text] [Related]
30. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries.
Malik KU; Nasjletti A
Circ Res; 1976 Jan; 38(1):26-30. PubMed ID: 172259
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin inhibits action of vagus nerve at the heart.
Potter EK
Br J Pharmacol; 1982 Jan; 75(1):9-11. PubMed ID: 7074289
[TBL] [Abstract][Full Text] [Related]
32. Norepinephrine and the presynaptic control of adrenergic transmitter release.
Bevan JA
Fed Proc; 1978 Feb; 37(2):187-90. PubMed ID: 23964
[No Abstract] [Full Text] [Related]
33. Myotropic actions of angiotensin and noradrenaline in strips of rabbit aortae.
St-Louis J; Regoli D; Barabé J; Park WK
Can J Physiol Pharmacol; 1977 Oct; 55(5):1056-69. PubMed ID: 922584
[No Abstract] [Full Text] [Related]
34. Myotropic affinities of angiotensin II and des-AspI-angiotensin II in rabbit aorta and femoral artery by microassay.
Waugh WH; Bales TE
Can J Physiol Pharmacol; 1979 Nov; 57(11):1256-66. PubMed ID: 519529
[No Abstract] [Full Text] [Related]
35. The preferential inhibitory effect of olmesartan, a new angiotensin II type 1 antagonist, on sympathetic nerve terminals in isolated canine splenic artery.
Chiba S; Yang XP
J Pharmacol Sci; 2003 Aug; 92(4):381-6. PubMed ID: 12939523
[TBL] [Abstract][Full Text] [Related]
36. Offset of actions of angiotensin II, angiotensin III, and their analogue antagonists in renal and femoral vascular beds: further evidence for different vascular angiotensin receptors.
Caldicott WJ; Hollenberg NK
Life Sci; 1979 Feb; 24(6):503-12. PubMed ID: 219313
[No Abstract] [Full Text] [Related]
37. Functional angiotensin receptor on cultured bovine chromaffin cells: secretory response to angiotensin II and angiotensin III.
Brust I; Printz MP
Clin Exp Hypertens A; 1988; 10(6):1321-3. PubMed ID: 3224438
[TBL] [Abstract][Full Text] [Related]
38. A comparison of angiotensin II and angiotensin III as vasoconstrictors in the mesenteric circulation of dogs.
Britton SL; Sexton JM; Fiksen-Olsen MJ; Werness PG; Romero JC
Circ Res; 1980 Jan; 46(1):146-51. PubMed ID: 7349914
[No Abstract] [Full Text] [Related]
39. Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation.
Blumberg AL; Nishikawa K; Denny SE; Marshall GR; Needleman P
Circ Res; 1977 Aug; 41(2):154-8. PubMed ID: 194728
[TBL] [Abstract][Full Text] [Related]
40. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight.
English V; Cassis L
J Neural Transm (Vienna); 1999; 106(7-8):631-44. PubMed ID: 10907723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
